Cereneo AG
10
3
3
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
30.0%
3 terminated/withdrawn out of 10 trials
40.0%
-46.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
SwissNeuroRehab - HDHI
Role: collaborator
Movement-activated Auricular Vagus Nerve Stimulation in Rehabilitation
Role: collaborator
Precision Sensorimotor Neurorehabilitation Through Personalized Stimulation Loops
Role: collaborator
Precision Sensorimotor Neurorehabilitation Through Personalized Stimulation Loops
Role: collaborator
Investigating Adherence to Cereneo Tele-service Support After Clinical Disharge in Stroke Patients
Role: lead
Feedback and Rewards to Increase Motivation for Therapy in Stroke Rehabilitation
Role: lead
Survey of Lifelong Food and Nutrition Assistance (LIFANA) in Stroke Patients and Caregivers
Role: lead
Acoustic Cueing During Slow-wave Sleep as a Measure to Improve Motor Rehabilitation Outcome in Stroke Patients
Role: collaborator
ArmeoSenso - Reward
Role: lead
Advanced Robotic Training With Additional Degrees of Freedom: Towards a Free-walking System
Role: lead
All 10 trials loaded